Indications
Kostaive is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. The use of this vaccine should be in accordance with official recommendations.
Composition
- Active substance
- COVID-19 sa-mRNA Vaccine
- International name (INN)
- zapomeran
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Kostaive
- Active substance
- COVID-19 sa-mRNA Vaccine
- ATC code
- J07BN01
- Therapeutic area
- COVID-19 virus infection
- Marketing authorisation holder